Editorial: It s time to speed up the rollout of vaccines
7 Mar, 2021 04:00 PM
3 minutes to read
A patient is vaccinated in Los Angeles. The United States is vaccinating at a rate of two million people a day. Photo / AP
A patient is vaccinated in Los Angeles. The United States is vaccinating at a rate of two million people a day. Photo / AP
NZ Herald
New Zealand has slipped back to a more normal normality under the pandemic, with a collective exhale of relief.
There s been days of no new community cases. The triple jolt of offshore earthquakes had a side-effect of reminding us that cooperation helps us get through.
By Thomas M. Burton WASHINGTON U.S. government scientists are pushing back against calls for one-dose regimens for two Covid-19 vaccines designed to be administered with two shots, saying there isn t enough evidence that a single dose provides long-term protection. It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death, Peter Marks, director of the Food and Drug Administration s center that oversees vaccines, told The Wall Street Journal. The FDA late last year approved a two-dose regimen for vaccines from Moderna Inc. and from a partnership of Pfizer Inc. and BioNTech SE. More recently it approved use of a one-dose regimen for a vaccine from Johnson & Johnson.
By Thomas M. Burton WASHINGTON U.S. government scientists are pushing back against calls for one-dose regimens for two Covid-19 vaccines designed to be administered with two shots, saying there isn t enough evidence that a single dose provides long-term protection. It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death, Peter Marks, director of the Food and Drug Administration s center that oversees vaccines, told The Wall Street Journal. The FDA late last year approved a two-dose regimen for vaccines from Moderna Inc. and from a partnership of Pfizer Inc. and BioNTech SE. More recently it approved use of a one-dose regimen for a vaccine from Johnson & Johnson.